Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Jieke Yan, Jing Guo, Yuzhen Wang, Xiaowei Xing, Xuguang Zhang, Guanghao Zhang & Zhaoqiang Dong. (2022) Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocardial infarction activity assessment. Drug Delivery 29:1, pages 2815-2823.
Read now
Read now
Mohammad Zaki Ahmad, Md. Rizwanullah, Javed Ahmad, Mohammed Yahia Alasmary, Md. Habban Akhter, Basel A. Abdel-Wahab, Musarrat Husain Warsi & Anzarul Haque. (2022) Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy. International Journal of Polymeric Materials and Polymeric Biomaterials 71:8, pages 602-623.
Read now
Read now
Zhen Qu, Yuning Ren, Hongyu Shen, Huihui Wang, Lijie Shi & Deyong Tong. (2021) Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System. Drug Design, Development and Therapy 15, pages 3605-3616.
Read now
Read now
Na Yin, Hui Yu, Xiaodi Zhang & Xiaodan Lv. (2020) Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib. Drug Design, Development and Therapy 14, pages 4465-4475.
Read now
Read now
Yuan Hong, Shaomin Che, Beina Hui, Xiaoli Wang, Xiaozhi Zhang & Hailin Ma. (2020) Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine. Drug Design, Development and Therapy 14, pages 2263-2274.
Read now
Read now
Yun Bian & Dong Guo. (2020) Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles. Drug Design, Development and Therapy 14, pages 647-659.
Read now
Read now
Junjian Wang. (2020) Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles. Drug Design, Development and Therapy 14, pages 823-832.
Read now
Read now
Zhiyu Wang, Aimin Zang, Yaning Wei, Lin An, Dan Hong, Yan Shi, Jingnan Zhang, Shenyong Su & Guotao Fang. (2020) Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer. Drug Design, Development and Therapy 14, pages 1095-1105.
Read now
Read now
Yanping Shao, Wenda Luo, Qunyi Guo, Xiaohong Li, Qianqian Zhang & Jing Li. (2019) In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy. Drug Design, Development and Therapy 13, pages 2043-2055.
Read now
Read now
Yu Sakurai & Hideyoshi Harashima. (2019) Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opinion on Drug Delivery 16:9, pages 915-936.
Read now
Read now
Feng Yang, Aimei Li, Han Liu & Hairong Zhang. (2018) Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity. Drug Design, Development and Therapy 12, pages 3321-3333.
Read now
Read now
Zhiyu Wang, Yaning Wei, Guotao Fang, Dan Hong, Lin An, Ting Jiao, Yan Shi & Aimin Zang. (2018) Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers. Drug Design, Development and Therapy 12, pages 3171-3180.
Read now
Read now
Wendu Duan & Yan Liu. (2018) Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. Drug Design, Development and Therapy 12, pages 2149-2161.
Read now
Read now
Articles from other publishers (24)
Fatma Betül Arslan, Kıvılcım Öztürk, Ece Tavukçuoğlu, Süleyman Can Öztürk, Güneş Esendağlı & Sema Çalış. (2023) A novel combination for the treatment of small cell lung cancer: Active targeted irinotecan and stattic co-loaded PLGA nanoparticles. International Journal of Pharmaceutics 632, pages 122573.
Crossref
Crossref
Xu Zhang, Xinshe Li, Yunhao Zhao, Qing Zheng, Qiang Wu & Yougui Yu. (2022) Nanocarrier system: An emerging strategy for bioactive peptide delivery. Frontiers in Nutrition 9.
Crossref
Crossref
Prateeksha, Vivek K. Sharma, Xiaowen Liu, Diego A. Oyarzún, Ahmed M. Abdel-Azeem, Atanas G. Atanasov, Abd El-Latif Hesham, Saroj K. Barik, Vijai Kumar Gupta & Brahma N. Singh. (2022) Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics. Seminars in Cancer Biology 86, pages 706-731.
Crossref
Crossref
Jieke Yan, Jing Guo, Yuzhen Wang, Xiaowei Xing, Xuguang Zhang, Guanghao Zhang & Zhaoqiang Dong. (2022) Acute myocardial infarction therapy using calycosin and tanshinone co-loaded mitochondria targeted lipid-polymer hybrid nano-system: Preparation, characterization, and anti myocardial infarction activity assessment. Biomedicine & Pharmacotherapy 155, pages 113650.
Crossref
Crossref
Adriana Aurelia Chis, Anca Maria Arseniu, Claudiu Morgovan, Carmen Maximiliana Dobrea, Adina Frum, Anca Maria Juncan, Anca Butuca, Steliana Ghibu, Felicia Gabriela Gligor & Luca Liviu Rus. (2022) Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics 14:9, pages 1773.
Crossref
Crossref
Lisa Efriani Puluhulawa, I Made Joni, Khaled M. Elamin, Ahmed Fouad Abdelwahab Mohammed, Muchtaridi Muchtaridi & Nasrul Wathoni. (2022) Chitosan–Hyaluronic Acid Nanoparticles for Active Targeting in Cancer Therapy. Polymers 14:16, pages 3410.
Crossref
Crossref
Yuan Sun, Cathleen M. Fry, Aileen Shieh, Xiangchen Cai, Thomas J. Reardon & Jon R. Parquette. (2022) Self-assembly of a 5-fluorouracil and camptothecin dual drug dipeptide conjugate. Organic & Biomolecular Chemistry 20:26, pages 5254-5258.
Crossref
Crossref
Dina Ashraf Hafez, Doaa A. Abdelmonsif, Rania G. Aly, Wael Mahmoud Samy, Kadria A. Elkhodairy & Noha Khalifa Abo Aasy. (2022) Role of fennel oil/ quercetin dual nano-phytopharmaceuticals in hampering liver fibrosis: Comprehensive optimization and in vivo assessment. Journal of Drug Delivery Science and Technology 69, pages 103177.
Crossref
Crossref
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, Farid Hashemi, Amirhossein Zabolian, Fardin Hashemi, Pourya Raee, Shahin Aghamiri, Milad Ashrafizadeh, Amir Reza Aref, Michael R. Hamblin, Kiavash Hushmandi, Ali Zarrabi & Gautam Sethi. (2021) Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytotherapy Research 36:1, pages 189-213.
Crossref
Crossref
Ge Chen, Yaozhong Zhang, Haowen Deng, Zilong Tang, Junjie Mao & Lei Wang. (2020) Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines. Biomedicine & Pharmacotherapy 125, pages 109988.
Crossref
Crossref
Juntao Pang, Huaixin Xing, Yingui Sun, Shuo Feng & Suzhen Wang. (2020) Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab. Biomedicine & Pharmacotherapy 125, pages 109861.
Crossref
Crossref
Jaleh Varshosaz, Monireh M. Fard, Mina Mirian & Farshid Hassanzadeh. (2020) Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma. Anti-Cancer Agents in Medicinal Chemistry 20:3, pages 346-358.
Crossref
Crossref
Ali Dehshahri, Milad Ashrafizadeh, Elham Ghasemipour Afshar, Abbas Pardakhty, Ali Mandegary, Reza Mohammadinejad & Gautam Sethi. (2020) Topoisomerase inhibitors: Pharmacology and emerging nanoscale delivery systems. Pharmacological Research 151, pages 104551.
Crossref
Crossref
Begum Dariya, Eluri Pavitra, Saimila Momin & Ganji Seeta Rama Raju. 2020. Theranostics Approaches to Gastric and Colon Cancer. Theranostics Approaches to Gastric and Colon Cancer
231
250
.
Ming-Hsien Lin, Chi-Feng Hung, Ching-Yun Hsu, Zih-Chan Lin & Jia-You Fang. (2019) Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency. Future Medicinal Chemistry 11:16, pages 2131-2150.
Crossref
Crossref
Lawrence B. Mensah, Stephen W. Morton, Jiahe Li, Haihua Xiao, Mohiuddin A. Quadir, Kevin M. Elias, Emily Penn, Aysen K. Richson, Paiman Peter Ghoroghchian, Joyce Liu & Paula T. Hammond. (2019) Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer. Bioengineering & Translational Medicine 4:2.
Crossref
Crossref
Yingli Zhang, Ping Zhang & Tao Zhu. (2019) Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery. Biomedicine & Pharmacotherapy 109, pages 475-483.
Crossref
Crossref
Oana Gherasim, Roxana Cristina Popescu, Tudor George Gherasim, Valentina Grumezescu & Ecaterina Andronescu. 2019. Nanoparticles in Pharmacotherapy. Nanoparticles in Pharmacotherapy
1
21
.
Deeptashree Nandi, Aakriti Singal & Alo Nag. 2019. Bioactive Natural Products for the Management of Cancer: from Bench to Bedside. Bioactive Natural Products for the Management of Cancer: from Bench to Bedside
177
218
.
Nayla Mouawad, Maguie El Boustani, Vincenzo Canzonieri, Isabella Caligiuri & Flavio Rizzolio. 2019. Gastric Cancer In The Precision Medicine Era. Gastric Cancer In The Precision Medicine Era
213
247
.
Saurabh Srivastava, Shadab Mohammad, Aditya Bhushan Pant, Prabhat Ranjan Mishra, Gitu Pandey, Shalini Gupta & Sana Farooqui. (2018) Co-delivery of 5-Fluorouracil and Curcumin Nanohybrid Formulations for Improved Chemotherapy Against Oral Squamous Cell Carcinoma. Journal of Maxillofacial and Oral Surgery 17:4, pages 597-610.
Crossref
Crossref
Guowen Wang, Zuyi Wang, Chuankui Li, Guixin Duan, Kangwu Wang, Qicai Li & Tao Tao. (2018) RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy. Biomedicine & Pharmacotherapy 106, pages 275-284.
Crossref
Crossref
Zizheng Song, Yan Shi, Quanli Han & Guanghai Dai. (2018) Endothelial growth factor receptor-targeted and reactive oxygen species-responsive lung cancer therapy by docetaxel and resveratrol encapsulated lipid-polymer hybrid nanoparticles. Biomedicine & Pharmacotherapy 105, pages 18-26.
Crossref
Crossref
Merve KarpuzMine Silindir-GunayAsuman Yekta Ozer. (2018) Current and Future Approaches for Effective Cancer Imaging and Treatment. Cancer Biotherapy and Radiopharmaceuticals 33:2, pages 39-51.
Crossref
Crossref